{"id":2424,"date":"2007-07-03T20:43:05","date_gmt":"2007-07-03T19:43:05","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=2424"},"modified":"2013-09-20T15:59:13","modified_gmt":"2013-09-20T15:59:13","slug":"roche-patent-for-hepatitis-c-drug-challenged-in-india","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/2424","title":{"rendered":"Roche patent for hepatitis C drug challenged in India"},"content":{"rendered":"<p><strong>The Indian Patent Office has received a challenge against Hoffmann-La Roche\u0092s patent rights for the hepatitis C drug Pegasys.<\/strong><\/p>\n<p>Public interest groups have said that patent protection and the resultant high price of the drug is making it unaffordable for an estimated 12.5 million Hepatitis C infected people in India. The groups also argued that the product was not an innovation and hence not eligible for patent protection.<\/p>\n<p>Sankalp, a Mumbai-based non-governmental organisation that provides treatment and rehabilitation support to injecting drug users, backed by a group of NGOs led by Lawyers Collective, filed the opposition with the Patent Office on May 18.<\/p>\n<p>Absence of patent protection could help Indian pharmaceutical companies develop cheap reverse-engineered versions of Pegasys, it said.<\/p>\n<p>Source: Business Standard (12 June, 2007)<br \/>\n<a href=\"http:\/\/www.i-base.info\/htb\/v8\/htb8-6-7\/%0D%0Dhttp:\/\/www.business-standard.com\/search\/storypage_new.php?leftnm=1&amp;leftindx=1&amp;subLeft=1&amp;autono=287446\">http:\/\/www.business-standard.com\/search\/storypage_new.php?leftnm=1&amp;leftindx=1&amp;subLeft=1&amp;autono=287446<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Indian Patent Office has received a challenge against Hoffmann-La Roche\u0092s patent rights for the hepatitis C drug Pegasys. Public interest groups have said that patent protection and the resultant high price of the drug is making it unaffordable for &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[38],"tags":[],"class_list":["post-2424","post","type-post","status-publish","format-standard","hentry","category-treatment-access"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/2424","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=2424"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/2424\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=2424"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=2424"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=2424"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}